Group D

Group E (male subjects only)

Number (male)

7 (7)

5 (3)

Age (years)

54.4 ± 8.4

51.6 ± 2.8 (50.0 ± 4.9)

BMI (kg/m2)

28.9 ± 2.6

30.1 ± 2.1 (29.7 ± 2.3)

Body fat percentage (%)

27.8 ± 5.9

32.8 ± 9.0 (31.3 ± 7.1)

Body muscle percentage (%)

28.2 ± 2.6

24.4 ± 7.0 (25.6 ± 5.5)

75% PWC (Watt)

104.6 ± 37.2

121.8 ± 50.5 (153.7 ± 19.2 )

Physical activity level (Mets∙h/week)

28.8 ± 12.8

21.1 ± 12.3 (27.4 ± 6.9)

Daily calorie intake (kcal/kg/day)

34.9 ± 5.8

30.3 ± 6.8 ( 28.8 ± 8.1)

Daily protein intake (g/kg/day)

1.23 ± 0.25

1.34 ± 0.32 (1.23 ± 0.35)

Daily salt intake (g/day)

10.4 ± 2.8

8.8 ± 3.3 (8.3 ± 2.4)

GFR (mL/min/1.73 m2)

80.1 ± 38.5

76.9 ± 26.1 (75.8 ± 16.6)

eGFRcre (mL/min/1.73 m2)

59.3 ± 26.9

64.2 ± 24.5 (63.8 ± 15.7)

Diabetes present

1

2

Hypertension present

7

4

Anti-RAS drug

7

4

Calcium channel blocker

4

3

Other type of antihypertensive drug

4

3

CKD classification

G1A3,

G2A1, G2A2, G2A3,

G3aA2, G3bA3, G4A3

G1A2, G1A3,

G2A2, G3aA2, G3aA3